IN8bio Statistics

Share Statistics

IN8bio has 3.44M shares outstanding. The number of shares has increased by -0.14% in one year.

Shares Outstanding	3.44M
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	-0.14%
Owned by Institutions (%)	25.97%
Shares Floating	2.93M
Failed to Deliver (FTD) Shares	2,587
FTD / Avg. Volume	1.2%

Short Selling Information

The latest short interest is 143.45K, so 4.16% of the outstanding shares have been sold short.

Short Interest	143.45K
Short % of Shares Out	4.16%
Short % of Float	4.79%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -13.58 and the forward PE ratio is -0.34. IN8bio's PEG ratio is 0.32.

PE Ratio	-13.58
Forward PE	-0.34
PS Ratio	0
Forward PS	0.2
PB Ratio	28.55
P/FCF Ratio	-17.04
PEG Ratio	0.32

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for IN8bio.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.35.

Current Ratio	4.08
Quick Ratio	4.08
Debt / Equity	0.35
Debt / EBITDA	-0.18
Debt / FCF	-0.21
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-1.69M
Employee Count	18
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -88.08% in the last 52 weeks. The beta is 0.01, so IN8bio's price volatility has been higher than the market average.

Beta	0.01
52-Week Price Change	-88.08%
50-Day Moving Average	2.51
200-Day Moving Average	6.27
Relative Strength Index (RSI)	49.83
Average Volume (20 Days)	215,557

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.44M
Net Income	-30.44M
EBITDA	-27.78M
EBIT	-30.44M
Earnings Per Share (EPS)	-0.57

Full Income Statement

Balance Sheet

The company has 11.12M in cash and 5.03M in debt, giving a net cash position of 6.09M.

Cash & Cash Equivalents	11.12M
Total Debt	5.03M
Net Cash	6.09M
Retained Earnings	-121.66M
Total Assets	19.87M
Working Capital	9.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -24.15M and capital expenditures -104K, giving a free cash flow of -24.25M.

Operating Cash Flow	-24.15M
Capital Expenditures	-104K
Free Cash Flow	-24.25M
FCF Per Share	-0.45

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for INAB is $108, which is 4657.7% higher than the current price. The consensus rating is "Buy".

Price Target	$108
Price Target Difference	4657.7%
Analyst Consensus	Buy
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jun 6, 2025. It was a backward split with a ratio of 1:30.

Last Split Date	Jun 6, 2025
Split Type	backward
Split Ratio	1:30

Scores

Altman Z-Score	-11.98
Piotroski F-Score	2

IN8bio Inc. (INAB)